237 related articles for article (PubMed ID: 24083458)
1. Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.
Poudel GR; Egan GF; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
J Psychiatry Neurosci; 2014 Mar; 39(2):87-96. PubMed ID: 24083458
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data.
Domínguez D JF; Poudel G; Stout JC; Gray M; Chua P; Borowsky B; Egan GF; Georgiou-Karistianis N
Cortex; 2017 Jul; 92():139-149. PubMed ID: 28482181
[TBL] [Abstract][Full Text] [Related]
3. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
4. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Exp Neurol; 2008 Sep; 213(1):137-44. PubMed ID: 18588876
[TBL] [Abstract][Full Text] [Related]
5. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Georgiou-Karistianis N; Poudel GR; Domínguez D JF; Langmaid R; Gray MA; Churchyard A; Chua P; Borowsky B; Egan GF; Stout JC
Brain Cogn; 2013 Oct; 83(1):80-91. PubMed ID: 23938592
[TBL] [Abstract][Full Text] [Related]
6. Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.
Georgiou-Karistianis N; Stout JC; Domínguez D JF; Carron SP; Ando A; Churchyard A; Chua P; Bohanna I; Dymowski AR; Poudel G; Egan GF
Hum Brain Mapp; 2014 May; 35(5):1847-64. PubMed ID: 23913754
[TBL] [Abstract][Full Text] [Related]
7. Altered resting-state connectivity in Huntington's disease.
Werner CJ; Dogan I; Saß C; Mirzazade S; Schiefer J; Shah NJ; Schulz JB; Reetz K
Hum Brain Mapp; 2014 Jun; 35(6):2582-93. PubMed ID: 23982979
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.
Gray MA; Egan GF; Ando A; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
Exp Neurol; 2013 Jan; 239():218-28. PubMed ID: 23123406
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease.
Gargouri F; Messé A; Perlbarg V; Valabregue R; McColgan P; Yahia-Cherif L; Fernandez-Vidal S; Ben Hamida A; Benali H; Tabrizi S; Durr A; Lehéricy S
Hum Brain Mapp; 2016 Nov; 37(11):4112-4128. PubMed ID: 27400836
[TBL] [Abstract][Full Text] [Related]
10. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers.
Labuschagne I; Poudel G; Kordsachia C; Wu Q; Thomson H; Georgiou-Karistianis N; Stout JC
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():11-16. PubMed ID: 28947180
[TBL] [Abstract][Full Text] [Related]
12. Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
Reyes A; Bartlett DM; Rankin TJ; Zaenker P; Turner K; Teo WP; Fu SC; Domingos J; Georgiou-Karistianis N; Ziman M; Cruickshank TM
Phys Ther; 2021 Apr; 101(4):. PubMed ID: 33482001
[TBL] [Abstract][Full Text] [Related]
13. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study.
Klöppel S; Gregory S; Scheller E; Minkova L; Razi A; Durr A; Roos RA; Leavitt BR; Papoutsi M; Landwehrmeyer GB; Reilmann R; Borowsky B; Johnson H; Mills JA; Owen G; Stout J; Scahill RI; Long JD; Rees G; Tabrizi SJ;
EBioMedicine; 2015 Oct; 2(10):1420-9. PubMed ID: 26629536
[TBL] [Abstract][Full Text] [Related]
14. Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.
Poudel GR; Stout JC; Domínguez DJ; Gray MA; Salmon L; Churchyard A; Chua P; Borowsky B; Egan GF; Georgiou-Karistianis N
Brain Struct Funct; 2015 Jan; 220(1):501-12. PubMed ID: 24240602
[TBL] [Abstract][Full Text] [Related]
15. Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance.
Minkova L; Eickhoff SB; Abdulkadir A; Kaller CP; Peter J; Scheller E; Lahr J; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
Hum Brain Mapp; 2016 Jan; 37(1):67-80. PubMed ID: 26453902
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.
Odish OF; van den Berg-Huysmans AA; van den Bogaard SJ; Dumas EM; Hart EP; Rombouts SA; van der Grond J; Roos RA;
Hum Brain Mapp; 2015 Jan; 36(1):110-9. PubMed ID: 25139578
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation.
Turner LM; Croft RJ; Churchyard A; Looi JC; Apthorp D; Georgiou-Karistianis N
PLoS One; 2015; 10(9):e0138563. PubMed ID: 26406226
[TBL] [Abstract][Full Text] [Related]
18. Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study.
Wilkes FA; Abaryan Z; Ching CRK; Gutman BA; Madsen SK; Walterfang M; Velakoulis D; Stout JC; Chua P; Egan GF; Thompson PM; Looi JCL; Georgiou-Karistianis N
Psychiatry Res Neuroimaging; 2019 Sep; 291():1-8. PubMed ID: 31330407
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal executive function associated coupling relates to Huntington's disease stage.
Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
[TBL] [Abstract][Full Text] [Related]
20. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
